Published in BMJ on November 30, 1996
Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. BMJ (2000) 2.08
Serum urate and the risk of major coronary heart disease events. Heart (1997) 1.46
Sucrose feeding in mouse pregnancy leads to hypertension, and sex-linked obesity and insulin resistance in female offspring. Front Physiol (2013) 0.90
Insulin resistance in adolescents with Down syndrome: a cross-sectional study. BMC Endocr Disord (2005) 0.88
Elevated insulin resistance in patients with recurrent aphthous stomatitis. Clin Oral Investig (2014) 0.75
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet (1963) 16.71
Fetal origins of coronary heart disease. BMJ (1995) 11.27
Metformin. N Engl J Med (1996) 7.66
Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16
Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med (1994) 5.28
Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med (1996) 5.20
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med (1995) 4.29
Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet (1996) 4.28
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med (1986) 3.90
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest (1985) 3.85
Insulin resistance in essential hypertension. N Engl J Med (1987) 3.78
Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med (1991) 3.58
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia (1991) 3.48
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Metabolic implications of body fat distribution. Diabetes Care (1991) 3.28
Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med (1996) 3.07
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med (1996) 2.92
Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med (1996) 2.77
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63
In defence of insulin: a critique of syndrome X. Lancet (1992) 2.62
Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia (1985) 2.48
Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med (1996) 2.42
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism (1978) 2.36
Hemodynamic actions of insulin. Am J Physiol (1994) 2.23
Trp64Arg mutation in beta 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet (1996) 2.09
Insulin and atheroma. 20-yr perspective. Diabetes Care (1990) 2.06
Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes (1996) 1.91
Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes (1996) 1.79
Addison's disease presenting as reduced insulin requirement in insulin dependent diabetes. BMJ (1996) 1.71
Insulin resistance: syndrome or tendency? Lancet (1995) 1.69
Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ (1989) 1.67
Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. BMJ (1994) 1.60
Hexosamines and insulin resistance. Diabetes (1996) 1.57
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52
Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med (1992) 1.47
The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group. Diabetes Care (1996) 1.41
On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia (1990) 1.26
Dietary fats and insulin action. Diabetologia (1996) 1.21
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Mutant insulin receptors in syndromes of insulin resistance. Baillieres Clin Endocrinol Metab (1996) 1.08
Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes (1995) 1.03
Comparative tolerability profiles of oral antidiabetic agents. Drug Saf (1994) 1.03
Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia (1993) 0.99
Insulin resistance and risk factors for coronary heart disease. Baillieres Clin Endocrinol Metab (1993) 0.97
Leptin in obesity. BMJ (1996) 0.93
Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia (1995) 0.91
Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia (1991) 0.87
Candidate genes for insulin resistance. Diabetes Care (1996) 0.86
Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabet Med (1992) 0.81
How to measure insulin action in vivo. Diabetes Metab Rev (1994) 0.81
Insulin resistance: a multifaceted metabolic syndrome. Insights gained using a low-dose insulin infusion technique. Diabet Med (1996) 0.80
Insulin resistance in offspring of hypertensive parents. BMJ (1993) 0.79
Is insulin atherogenic? Diabet Med (1992) 0.78
Drugs on the horizon for treatment of type 2 diabetes. Diabet Med (1995) 0.78
Clinical significance of insulin resistance. Diabet Med (1996) 0.76